An Indian state of Uttar Pradesh reported the first case where a person got COVID-19 positive even after getting a 2-dose course of the Covaxin vaccine.
Must Watch: Would you live on 3D Printed Mars for a year for $60,000?
The person is a Lucknow-based doctor Nitin Mishra, who works as emergency medical officer at the Civil hospital. He had received a complete 2-dose course of Covaxin on February 15, 2021 followed by a second dose on March 16, 2021.
However, just after 2 days of getting the second dose, he got a severe cough along with mild fever on March 18. When he got himself tested on March 20, he was found suffering with COVID-19.
After getting the test results, he isolated himself at home and regularly started monitoring his blood pressure and blood oxygen levels on regular basis.
Subhash Chandra Sundariyal, Director of the Civil Hospital said that, “We are also in touch with him and in case, symptoms aggravate, he will be hospitalized. The entire hospital has been sanitized and services are continuing as usual.”
Subscribe to GreatGameIndia
Prof Amita Jain, head of the Microbiology Department in King George’s Medical University, said, “It takes a few weeks, even after completion of the vaccination course, to build full immunity against the disease. During this period, a person may get infected and develop symptoms.”
The Director General of Medical Health, Dr. Negi said “Data shows that the efficacy of Covaxin is about 80-90 per cent. The vaccine does not act as a shield against infection, but protects a person from falling critically ill, hence people should go for the vaccine, if they are medically eligible, without any hesitation.”
Covaxin has been indigenously developed in India by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
However, as GreatGameIndia reported contrary to popular belief, the “Swadeshi” Indian COVID-19 vaccine COVAXIN maker Bharat Biotech was backed since its inception by Bill Gates and the international pharma lobby.
Bharat Biotech is the first Indian company to receive massive grants from the Bill & Melinda Gates Foundation for vaccine against Rotavirus called Rotavac.
The vaccine was given green light by the authorities even before its trials were complete and its efficacy is mired in controversy till today with cases pending in the Supreme Court.
For latest updates on the outbreak check out our Coronavirus Coverage.